We are live on
!
Find out more
VM
Valor Management Portfolio holdings
AUM
$181M
1-Year Est. Return
6.67%
This Fund
S&P 500
This Quarter
Est. Return
-12.82%
1 Year Est. Return
+6.67%
3 Year Est. Return
+15.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
-$225M
(-48%)
Cap. Flow
-$161M
Cap. Flow
% of AUM
-64.6%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BWAY
Brainsway
BWAY
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harmony Biosciences
HRMY
|
+$158M |
| 2 |
Astera Labs
ALAB
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.39% |
| 2 | Consumer Discretionary | 0.61% |
| 3 | Technology | 0% |
Similar funds
AA
MGW
TWP
MPG
BRPW
ATIA
FFA
RWP
Valor Management's Q4 2024 Portfolio in Review
As of Q4 2024, Valor Management held 5 positions worth $249M, down 48% from $475M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Valor Management withdrew a net $161M in Q4 2024, closing 1 position and reducing 1 holding. Its most notable exit was Astera Labs, an estimated $23.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 95% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Valor Management opened a new position in Brainsway worth $19.8M.
- Valor Management's largest Q4 2024 buy was Brainsway: 4,207,490 shares worth $19.8M.
- Valor Management's biggest Q4 2024 reduction was Harmony Biosciences, cutting an estimated $158M.
- Valor Management fully exited Astera Labs in Q4 2024, selling an estimated $23.4M.
- Valor Management's ten largest holdings make up 100% of its $249M portfolio in Q4 2024.
- Valor Management opened 1 new position and closed 1 in Q4 2024.
- Valor Management's portfolio value fell 48% quarter-over-quarter to $249M.
Based on Valor Management's 13F filing for Q4 2024, filed 14 Feb 2025.